DISCUSSION ON SOME BLOOD DISORDERS Hypersplenism By M. C. G. ISRAELS, M.D., F.R.C.P.
(University Department of Haematology, Manchester) THE idea of a primary disease due to over-activity of the spleen was suggested about ten years ago by Doan, Dameshek and their colleagues in the U.S.A. The essential criteria for diagnosis were: (1) An enlarged spleen. (2) Depression of one or more of the red cells, granulocytes, or platelets in the peripheral blood-anmemia, granulocytopenia or thrombocytopenia. (3) Activity in the bone-marrow of the cell series depressed in the peripheral blood; e.g. anaemia accompanied by intense erythroblastic activity in the marrow.
It followed that if these three criteria were met, the proper treatment for the patient was removal of the spleen. Then, presumably, relieved of the excessive sequestration and destruction in the spleen of the affected cells, the blood count would return to normal and the patient would be cured of his symptoms. This response made a fourth criterion.
Our attitude to primary hypersplenism has slowly changed as causes have been found for many of the cases originally labelled primary, and now a case can be made out for doubting the existence of the syndrome.
In 1950 a note of caution appeared in the work of Dameshek and Estren and a fifth point was added to the criteria, viz. that the histology of the spleen must be normal. This meant that the clinical diagnosis of primary hypersplenism was always open to histological correction.
No one will deny that a syndrome of secondary hypersplenism exists. If cells are unusually sequestrated in the spleen, they will be destroyed more rapidly. The classical example is congenital spherocytosis in which the anamia is largely relieved by removal of what is often a grossly enlarged spleen. But the primary defect is the congenitally abnormal shape of the red cells, and the histology of the spleen is far from normal, showing over-filling of the pulp with red cells and resultant compression of the other splenic structures.
The classical example of primary hypersplenism was considered to be the syndrome known as acquired hxmolytic anmmia. Here there is grave anemia, the bone-marrow shows intense normoblastic activity with pro-erythroblasts present; the spleen is much enlarged and on section the main structure remains normal, the only abnormality being some hyperplasia of reticulum cells in the sinuses.
But we have learnt from experience that splenectomy often only partially relieves the anemia in this disease. The advent of the Coombs antiglobulin reaction has enabled us to establish the presence of h2emolytic antibodies which had been long suspected.
Nowadays most of these patients are successfully controlled by cortisone treatment and splenectomy is only carried out on the few who fail to respond. It is clear that acquired hemolytic anemia is not a primary hypersplenism; the spleen is probably taking part in the production of abnormal antibody and its normal activity of sequestration and destruction of red cells is increased because the red cells affected by the antibody have a much shortened survival. The hypersplenism is only part of the pathological picture in this disease.
In another group, the presence of a large spleen as the sole clinical finding together with typical findings in the blood and bone-marrow have led to splenectomy; but the sections of the spleen have shown that one or other of the reticuloses is present and the prognosis is that of the primary condition (Israels, 1953) . Splenic neutropenia is a rare syndrome. I have seen patients with chronic neutropenia but without enlarged spleens; the two patients with enlarged spleens and neutropenia but no anemia or thrombocytopenia have turned out to have chronic infections and we have not yet removed their spleens.
From experiences such as this, it is clear that splenomegaly and primary hypersplenism may well be a non-existent combination. We do know that hypersplenism can arise during the course of another blood disease and that the effects can be temporarily alleviated by splenectomy. The cases of hypersplenism occurring in the course of chronic lymphatic leukemia and in myelosclerosis are examples.
For all these reasons the combination of a large spleen with anemia, granulocytopenia or thrombocytopenia means a secondary hypersplenism, and whether we recommend splenectomy will depend on what we think the primary disease is likely to be.
Thrombocytopenic purpura does appear to be a form of hypersplenism which fulfils the criterion that splenectomy will be effective. In a series of 65 cases of thrombocytopenic purpura who had the spleen removed, 73 % showed a completely satisfactory response; i.e. the purpuric manifestations disappeared and the platelets rose to normal levels and stayed there; in 19 % the platelets stabilized at a subnormal level and the patients continued to have minor purpuric symptoms; in only 5% did the operation fail completely. In thrombocytopenic purpura, there is thrombocytopenia, an active marrow containing megakaryocytes, a good response to splenectomy, and the histology of the spleen shows no abnormality of the main structure; sometimes there is reticulum-cell hyperplasia in the Malpighian bodies. But there is never a palpably enlarged spleen, indeed it is axiomatic that if the spleen is very large, the condition is not primary. At operation the spleen is usually found to be two or three times as large as normal, but this does not make it palpable in the normal person. So in the sole survivor of the primary hypersplenic syndrome, we are paradoxically denied the sign of a palpable enlarged spleen. The work on anti-platelet antibodies may place thrombocytopenic purpura in the same class of diseases as acquired himolytic anaemia. So far the evidence is too conflicting for acceptance (Lancet, 1955) and so far thrombocytopenic purpura remains an apparently primary hypersplenism.
The physician should recommend splenectomy in this group of diseases in three conditions:
(1) In thrombocytopenic purpura, after a sufficient time, usually one month, has been allowed for spontaneous remission or for cortisone to induce a remission.
(2) In congenital spherocytosis, because experience has taught us that relief can be expected in 99 % of cases.
(3) In follicular lympho-reticulosis, where diagnosis is possible. The points are a grossly enlarged spleen, a patient who is remarkably well in spite of his abdominal mass and blood abnormalities, and the spleen puncture should show only lymphocytes.
In all other cases splenectomy should be avoided if possible. Sometimes splenectomy is recommended as a diagnostic measure and in the hope of temporary relief. But the prognosis should then be very guarded. affected cases is probably high because it is in these patients that difficulty in diagnosis arises. They live normal lives and hmmorrhage is nearly always related to definite trauma. Hemarthroses are uncommon and the joints never show any permanent damage.
Analysing the results for all the mildly affected patients the A.H.G. levels have varied between about 1 and 30%. Practically all of the patients with more than 5% of A.H.G. are very mildly affected but we have seen patients whom we consider have hvmophilia with as much as 30% and 2 patients of rather doubtful diagnosis with more than 30%.
It is of interest to see what happens when these patients are subjected to operation. Since the bleeding tendency is usually disclosed only by trauma quite a high proportion of patients give a history of previous dental extraction or operation. 26 gave a history of dental extraction and without treatment all had bled for a week or more and 7 required transfusion.
12 patients gave a history of previous tonsillectomy and 2 patients told us that an affected relative had died after tonsillectomy. The A.H.G. levels and history of transfusions in these patients is shown in Table I . Patients with more than 15% A.H.G. do better than those with less than I0O%. 7 patients had had appendicectomy and this operation was surprisingly uneventful. 
Two general inferences emerge from the study of these patients. One is that bleeding is likely to occur in hmophilic patients with A.H.G. levels up to 30%o. In treating severely affected hemophilic patients whose initial level of antihoemophilic globulin is 0, no significant reduction in their bleeding tendency is likely to be achieved unless the level of antihlmophilic globulin can be raised above 150. Surgical procedures will not be safe unless the level can be raised above 30 %. TREATMENT OF HAMOPHILIA A.H.G. is present in plasma and can also be separated from plasma in a more or less concentrated form. We have observed the effects of surgical treatment in hemophilic patients both after fresh human plasma and after concentrated animal A.H.G. I shall discuss the treatment of severely affected patients.
HUMAN PLASMA
One of the difficulties in using human plasma is that the A.H.G. is very unstable and the plasma must either be used quite fresh (within hours of collection) or it must be stored with special precautions to prevent deterioration. We have found that storage at -300 C. may give adequate levels even after one to two months. 1,000 ml. of human plasma given to an adult hkmophiliac in 45-60 min. usually raises the level of A.H.G. to about 25 %. Very occasionally, patients have a greater rise, some seem resistant to treatment and the rise is much less. The level achieved by plasma transfusion, in fact, seldom raises the hxemophiliac out of the haemophilic range. This treatment does, however, bring the severely affected patient into the very mildly affected range.
For minor procedures such as dental extractions, this treatment reduces the bleeding under favourable circumstances but does not eliminate it altogether. We have found that with plasma treatment it is sometimes reasonably safe to remove as many as 12-16 teeth at one time. This policy is, however, undoubtedly hazardous and should not be undertaken without more potent antihemophilic material available in case of emergency.
The effects of a litre of plasma suggest that the dose of A.H.G. to reach a safe hxemostatic level must exceed 2 litres. Thus concentrated A.H.G. must be able to supply doses equivalent to 2-3 litres of human plasma in a reasonable volume of diluent. A mistake that has been made in the past is to assume that quite small amounts of A.H.G. are effective when to get a reasonable dose it would be necessary to dissolve the contents of 50-100 ampoules. This era is now passing and it is realized that to enter the ampoule scale in A.H.G. the material requires to be purified 2,000 to 10,000 times.
We have used concentrated animal A.H.G. initially for volunteers who needed dental extractions. 5 of such volunteers were treated and in all good solid clots formed in the sockets; in 3 healing was uneventful. One patient developed thrombocytopenia and on further investigation it was found that beef blood contains a species agglutinin for human platelets. This agglutinin is in the fraction containing A.H.G. Also one patient had an early allergic reaction. As a rule the low platelet levels are very temporary and do not affect hemostasis. But the one exceptional case who was adversely affected ordinarily had a rather low platelet count and was taking Epanutin for epilepsy. A.H.G. made from pig blood does not have this platelet-agglutinating effect.
Both pig and beef A.H.G. are antigenic and, so far, we have never attempted to give mnore than one course of treatment, that is ten days of daily injections of material from one animal species. For this reason after the first volunteers the animal A.H.G. has been ised only for patients who are liable to die unless they are treated with animal A.H.G. Patients treated surgically who received animal A.H.G. included (1) a young man who LAWd received an accidental gunshot wound of the back and arm and required the removal of a traumatic arteriovenous aneurism from the brachial artery. His case is described in detail by Fraenkel and Honey (1955) . (2) A young man who had a head injury from a motor cycle accident, and (3) a boy of 15 who had an operation involving the removal of laminae from 12 vertebre for the treatment of a massive extradural clot.
The present position then is that plasma and blood transfusion cannot raise the A.H.G. level of a severely affected patient to the normal range. What this treatment can do is to raise the level to the top of the range for mild hkmophiliacs. For many purposes such as the control of spontaneous epistaxis or hkmaturia this may be adequate but for more serious lesions better levels are required. At present higher A.H.G. levels can only be obtained by using animal material. REFERENCE FRAENKEL, G. J., and HONEY, G. E. (1955) Lancet, ii, 1117. accompanying reticulosarcoma and allied lymphomas; and (3) in "idiopathic" acquired hmmolytic animia of the cold-antibody type. Patients presenting symptoms of the cold hamagglutinin syndrome belong to this last group. In addition, cold agglutinins at abnormally high titres have been reported from time to time in a wide variety of disorders, ranging from liver disease to trypanosomiasis, but such reports mostly lack details of titres, &c., and one is not always sure whether the auto-agglutination is due to the presence of cold agglutinins or excessive rouleaux formation. The incidence of cold agglutinins at raised titres in what may be termed "miscellaneous disorders" is in any case low. Finland and his colleagues (1945), for instance, studied 809 sera from patients suffering from a variety of disorders, mainly infections, and found only nine sera containing cold agglutinins at titres exceeding 80, and even so, four of these sera came from patients with haemolytic anemia.
I shall discuss acquired hkmolytic animias of the cold-antibody type, of unknown origin, and those patients whose serum contains cold antibodies at titres in excess of 8,000 at 2-4°C., for these are the patients who present the symptoms of the cold hmmagglutinin syndrome. The first well-documented reports of this syndrome date from 1935. In that year Roth and Ermstene, and Gardner, in America, and Salen in Sweden, all described patients thought to be suffering from paroxysmal hkmoglobinuria, who in retrospect clearly were suffering from the syndrome under discussion.
The incidence of this type of hemolytic animia is illustrated in Table I . The data comprise patients with acquired heemolytic aneemia personally studied during the last ten years. Of the 15 patients with cold auto-antibodies, 10 were diagnosed as having the coldhaemagglutinin syndrome, for they all suffered from well-marked Raynaud's phenomena, with or without hzemoglobinuria, in cold weather. (The other 5 patients were relatively free or completely free from these symptoms; they differed also in serological findings.)
The 10 patients with the cold hemagglutinin syndrome make an interesting series. Some clinical data are shown in Table II . The disease clearly affects elderly subjects and is of long duration; both sexes are affected. The patients suffer from a mild to moderately severe hmmolytic anemia. Some haematological data are shown in Table III . The patients are usually significantly more anemic in winter-time than in warm weather, but they are rarely completely free from anmmia in the summer-time (Fig. 1 ). If kept in bed their anemia lessens. This is probably the result of their being kept warm; it incidentally makes assessment of the possible benefit of any other form of therapy unusually difficult (Fig. 2) . In cold weather the patients regularly show Raynaud's phenomena. Their fingers feel cold and numb and may be painful, and become bluish-purple in colour. The ear lobes and the tip of the nose may be similarly affected. These changes are quickly reversible on warming the skin, but irreversible changes may occur and gangrene of the tips of the digits is not uncommon.
The circulatory changes appear to be due to auto-hvmagglutination taking place in the cutaneous blood vessels as the direct result of cooling of the skin. As in most cases autohkmagglutination takes place at temperatures extending up to 29-31°C., minor degrees of cooling are all that are necessary to bring this about. The cessation of circulation may be readily seen with a skin microscope or by examining the conjunctival blood vessels with the aid of a lens, after having irrigated the eye with cold saline. Heemoglobinuria is a less frequently observed symptom than Raynaud's phenomena, but most patients give a history of it at some time during the course of their illness. In some, it regularly occurs every cold winter's day. Even in its absence hkemosiderin may be found in the urine deposit. Most patients, too, are visibly jaundiced in winter-time. Their spleens are usually palpable but are seldom very large. SEROLOGICAL FINDINGS Most characteristic is the rapid spontaneous hemagglutination which takes place at room temperature, making spreading blood films and counting red cells by ordinary techniques difficult or impossible. However, if the blood is collected in a warmed syringe, kept at 370 C. subsequently, and then diluted with warmed diluent and placed in a warm counting chamber, counts are perfectly possible. Similarly, serum free from hkmolysis may be obtained if the patient's blood is allowed to clot undisturbed in a warm vessel at 370 C.
The serological findings in these patients are remarkable. The range of cold-agglutinin titres, and other data, are given in Table IV . Normal red cells are not agglutinated at 37°C. The direct antiglobulin (Coombs) test is positive, even if care is taken to keep the sample of blood strictly at 370 C. before the test is carried out. The indirect antiglobulin test is usually negative at 370 C. but strongly positive if the sensitization is carried out at temperatures below 300 C. .. Present in 3 out of 10 sera ("Cryocrit" 1 0-5 0%) Serum complement..
.. ..
Range
Normal range (units) (units) 10-90 50-150 (3 out of 5 subnormal) W.R. and Kahn reactions ..
Uniformly negative

